Tailoring in vitro cell responses of porous silicon micro- and nanoparticles

Hélder A. Santos, Luis M. Bimbo, Jarno Salonen, Vesa-Pekka Lehto, Jouni Hirvonen

Research output: Contribution to journalArticle

Abstract

Biomedical applications of inorganic nanomaterials have been actively investigated recently, especially in areas such as imaging and drug delivery applications. These materials are thought to improve the efficiency of cancer therapy and to provide efficient and user-friendly administration of other active
pharmaceutical ingredients. For example, many potential molecules cannot be delivered in oral form due to their poor dissolution/solubility and/or pharmacokinetic properties in the intestinal lumen, poor permeation properties in the GI tract, and high intestinal or hepatic first-pass metabolism. Porous silicon
(PSi) materials have several advantages over existing materials for drug delivery, overcoming most of the abovementioned problems in drug delivery of poorly soluble drug molecules. They can be fabricated to be stable under the harsh conditions of the stomach and GI lumen, maintaining their physicochemical
properties. In addition, PSi particles possessing different pore sizes in the mesoporous range (2–50 nm), along with desired surface chemistry, morphology, and high surface areas (200–700 m2/g), enable utilization of tailored PSi particles, with optimal loading of drug molecules into the pores, resulting in, for
example, improved drug release/dissolution and permeation behavior.
LanguageEnglish
Pages10-11
Number of pages2
JournalCRS Newsletter
Volume27
Issue number1
Publication statusPublished - 2010
Externally publishedYes

Fingerprint

Porous silicon
Silicon
Drug delivery
Nanoparticles
Permeation
Molecules
Dissolution
Pharmaceutical Preparations
Pharmacokinetics
Surface chemistry
Nanostructured materials
Metabolism
Pore size
Solubility
Nanostructures
Imaging techniques
Gastrointestinal Tract
Stomach
In Vitro Techniques
Liver

Keywords

  • drug delivery
  • porous silicon
  • drug molecules

Cite this

Santos, H. A., Bimbo, L. M., Salonen, J., Lehto, V-P., & Hirvonen, J. (2010). Tailoring in vitro cell responses of porous silicon micro- and nanoparticles. CRS Newsletter, 27(1), 10-11.
Santos, Hélder A. ; Bimbo, Luis M. ; Salonen, Jarno ; Lehto, Vesa-Pekka ; Hirvonen, Jouni. / Tailoring in vitro cell responses of porous silicon micro- and nanoparticles. In: CRS Newsletter. 2010 ; Vol. 27, No. 1. pp. 10-11.
@article{d0ef3f5f90a4487db5e02c6e30e19b9c,
title = "Tailoring in vitro cell responses of porous silicon micro- and nanoparticles",
abstract = "Biomedical applications of inorganic nanomaterials have been actively investigated recently, especially in areas such as imaging and drug delivery applications. These materials are thought to improve the efficiency of cancer therapy and to provide efficient and user-friendly administration of other activepharmaceutical ingredients. For example, many potential molecules cannot be delivered in oral form due to their poor dissolution/solubility and/or pharmacokinetic properties in the intestinal lumen, poor permeation properties in the GI tract, and high intestinal or hepatic first-pass metabolism. Porous silicon(PSi) materials have several advantages over existing materials for drug delivery, overcoming most of the abovementioned problems in drug delivery of poorly soluble drug molecules. They can be fabricated to be stable under the harsh conditions of the stomach and GI lumen, maintaining their physicochemicalproperties. In addition, PSi particles possessing different pore sizes in the mesoporous range (2–50 nm), along with desired surface chemistry, morphology, and high surface areas (200–700 m2/g), enable utilization of tailored PSi particles, with optimal loading of drug molecules into the pores, resulting in, forexample, improved drug release/dissolution and permeation behavior.",
keywords = "drug delivery, porous silicon, drug molecules",
author = "Santos, {H{\'e}lder A.} and Bimbo, {Luis M.} and Jarno Salonen and Vesa-Pekka Lehto and Jouni Hirvonen",
year = "2010",
language = "English",
volume = "27",
pages = "10--11",
journal = "CRS Newsletter",
number = "1",

}

Santos, HA, Bimbo, LM, Salonen, J, Lehto, V-P & Hirvonen, J 2010, 'Tailoring in vitro cell responses of porous silicon micro- and nanoparticles' CRS Newsletter, vol. 27, no. 1, pp. 10-11.

Tailoring in vitro cell responses of porous silicon micro- and nanoparticles. / Santos, Hélder A.; Bimbo, Luis M.; Salonen, Jarno; Lehto, Vesa-Pekka; Hirvonen, Jouni.

In: CRS Newsletter, Vol. 27, No. 1, 2010, p. 10-11.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Tailoring in vitro cell responses of porous silicon micro- and nanoparticles

AU - Santos, Hélder A.

AU - Bimbo, Luis M.

AU - Salonen, Jarno

AU - Lehto, Vesa-Pekka

AU - Hirvonen, Jouni

PY - 2010

Y1 - 2010

N2 - Biomedical applications of inorganic nanomaterials have been actively investigated recently, especially in areas such as imaging and drug delivery applications. These materials are thought to improve the efficiency of cancer therapy and to provide efficient and user-friendly administration of other activepharmaceutical ingredients. For example, many potential molecules cannot be delivered in oral form due to their poor dissolution/solubility and/or pharmacokinetic properties in the intestinal lumen, poor permeation properties in the GI tract, and high intestinal or hepatic first-pass metabolism. Porous silicon(PSi) materials have several advantages over existing materials for drug delivery, overcoming most of the abovementioned problems in drug delivery of poorly soluble drug molecules. They can be fabricated to be stable under the harsh conditions of the stomach and GI lumen, maintaining their physicochemicalproperties. In addition, PSi particles possessing different pore sizes in the mesoporous range (2–50 nm), along with desired surface chemistry, morphology, and high surface areas (200–700 m2/g), enable utilization of tailored PSi particles, with optimal loading of drug molecules into the pores, resulting in, forexample, improved drug release/dissolution and permeation behavior.

AB - Biomedical applications of inorganic nanomaterials have been actively investigated recently, especially in areas such as imaging and drug delivery applications. These materials are thought to improve the efficiency of cancer therapy and to provide efficient and user-friendly administration of other activepharmaceutical ingredients. For example, many potential molecules cannot be delivered in oral form due to their poor dissolution/solubility and/or pharmacokinetic properties in the intestinal lumen, poor permeation properties in the GI tract, and high intestinal or hepatic first-pass metabolism. Porous silicon(PSi) materials have several advantages over existing materials for drug delivery, overcoming most of the abovementioned problems in drug delivery of poorly soluble drug molecules. They can be fabricated to be stable under the harsh conditions of the stomach and GI lumen, maintaining their physicochemicalproperties. In addition, PSi particles possessing different pore sizes in the mesoporous range (2–50 nm), along with desired surface chemistry, morphology, and high surface areas (200–700 m2/g), enable utilization of tailored PSi particles, with optimal loading of drug molecules into the pores, resulting in, forexample, improved drug release/dissolution and permeation behavior.

KW - drug delivery

KW - porous silicon

KW - drug molecules

UR - http://www.controlledreleasesociety.org

M3 - Article

VL - 27

SP - 10

EP - 11

JO - CRS Newsletter

T2 - CRS Newsletter

JF - CRS Newsletter

IS - 1

ER -